Nicholas Dignam - Alcon AG Director
| ALC Stock | USD 78.72 0.05 0.06% |
Director
Nicholas Dignam is Director of Alcon AG since 2016.
| Tenure | 8 years |
| Address | Chemin de Blandonnet 8, Geneva, Switzerland, 1214 |
| Phone | 41 589 112 110 |
| Web | https://www.alcon.com |
Alcon AG Management Efficiency
The company has Return on Asset of 0.0217 % which means that on every $100 spent on assets, it made $0.0217 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0483 %, implying that it generated $0.0483 on every 100 dollars invested. Alcon AG's management efficiency ratios could be used to measure how well Alcon AG manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.09. The current year's Return On Capital Employed is expected to grow to 0.05. At present, Alcon AG's Net Tangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.09, whereas Total Assets are forecasted to decline to about 24.5 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kyle Lattner | Acadia Healthcare | 29 | |
| Annie Lamont | HCA Holdings | 60 | |
| Geoffrey Meyers | HCA Holdings | 73 | |
| Michael Gaynor | Novo Integrated Sciences | 49 | |
| John Rowe | HCA Holdings | 72 | |
| William Grieco | Acadia Healthcare | 64 | |
| Chris Gordon | Acadia Healthcare | 44 | |
| Christopher Gordon | Acadia Healthcare | 44 | |
| Wade Miquelon | Acadia Healthcare | 53 | |
| Vicky Gregg | Acadia Healthcare | 63 | |
| EPerot Bissell | Acadia Healthcare | 58 | |
| Reeve Waud | Acadia Healthcare | 54 | |
| Jay Light | HCA Holdings | 74 | |
| Charles Holliday | HCA Holdings | 73 | |
| Robert Dennis | HCA Holdings | 67 | |
| Meg Crofton | HCA Holdings | 67 | |
| William Frist | HCA Holdings | 51 | |
| Wayne Riley | HCA Holdings | 61 | |
| NancyAnn DeParle | HCA Holdings | 64 | |
| William Petrie | Acadia Healthcare | 71 | |
| Ann Lamont | HCA Holdings | 58 | |
Management Performance
| Return On Equity | 0.0483 | ||||
| Return On Asset | 0.0217 |
Alcon AG Leadership Team
Elected by the shareholders, the Alcon AG's board of directors comprises two types of representatives: Alcon AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alcon. The board's role is to monitor Alcon AG's management team and ensure that shareholders' interests are well served. Alcon AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alcon AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Bahen, Non-Executive Director | ||
| Arthur MD, Executive Director | ||
| David Murray, Chief Financial Officer | ||
| Adela Verdugo, Vice Chairman of the Board, Quality Director | ||
| Scott Maw, Independent Director | ||
| Ines Poeschel, Independent Director | ||
| Thomas Glanzmann, Independent Director | ||
| Arthur Cummings, Independent Director | ||
| Ignacio Lopez, Director, Finance Director, Vice Secretary | ||
| Brian Leedman, Non-Executive Director | ||
| Lynn Bleil, Independent Director | ||
| Dieter Spalti, Independent Director | ||
| Nathan Buzza, Director | ||
| Constantino Pico, Chairman of the Board, CEO | ||
| Duncan Craig, Company Secretary | ||
| Ines Poschel, Independent Director | ||
| Laurent Attias, Head Corporate Development, Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A) | ||
| Dieter Spaelti, Independent Director | ||
| Malcolm Pradhan, Director | ||
| Ian Bell, President - Global Business and Innovation | ||
| Nicholas Dignam, Director | ||
| Royce Bedward, General VP | ||
| Michael Onuscheck, President - Global Businesses and Innovation | ||
| Carlos Toledo, Director, Representative of Ram Bhavnani's investment | ||
| Ed McGough, Senior Operations | ||
| Gavin Wates, Non-Executive Director | ||
| Sergio Duplan, President - North America | ||
| Loren Jones, Company Secretary | ||
| Raymond Blight, Director | ||
| Karen May, Independent Director | ||
| Teresa Garrido, Independent Director | ||
| Luis Huete, Director | ||
| Timothy Stonesifer, Chief Financial Officer | ||
| Michael Ball, Executive Chairman | ||
| Margaret Buckley, Chief Officer | ||
| Leon Fraustro, President - North America | ||
| Josh Puckridge, Non-Executive Director | ||
| S Attias, Head Corporate Development, Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A) | ||
| F Ball, Chairman of the Board ( Designate ) | ||
| D Grossman, Independent Vice Chairman of the Board, Lead Independent Director | ||
| Franck Leveiller, Head VP | ||
| David Endicott, Chief Executive Officer, Director | ||
| Kimberly Martin, VP Officer | ||
| Rajkumar Narayanan, Senior Vice President - Operational Strategy, Chief Transformation Officer | ||
| Manuel Cachafeiro, Director, Secretary | ||
| Ramon Pineiro, Director | ||
| Josefina Alvarez, Director | ||
| SueJean Lin, Senior Vice President, Chief Information and Transformation Officer | ||
| Fidel Hidalgo, Director, Corporate Development Director |
Alcon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alcon AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0483 | ||||
| Return On Asset | 0.0217 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 42.87 B | ||||
| Shares Outstanding | 493.24 M | ||||
| Shares Owned By Insiders | 0.14 % | ||||
| Shares Owned By Institutions | 65.83 % | ||||
| Number Of Shares Shorted | 3.33 M | ||||
| Price To Earning | 62.60 X |
Pair Trading with Alcon AG
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alcon AG position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alcon AG will appreciate offsetting losses from the drop in the long position's value.Moving together with Alcon Stock
| 0.82 | CAH | Cardinal Health Earnings Call Tomorrow | PairCorr |
Moving against Alcon Stock
| 0.55 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
| 0.55 | TFX | Teleflex Incorporated Earnings Call This Week | PairCorr |
| 0.54 | MMSI | Merit Medical Systems | PairCorr |
| 0.53 | SSY | SunLink Health Systems | PairCorr |
| 0.44 | VALN | Valneva SE ADR Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Alcon AG could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alcon AG when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alcon AG - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alcon AG to buy it.
The correlation of Alcon AG is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alcon AG moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alcon AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alcon AG can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Alcon Stock analysis
When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Alcon AG's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.783 | Dividend Share 0.285 | Earnings Share 1.96 | Revenue Per Share 19.178 | Quarterly Revenue Growth 0.083 |
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.